Cary J Claiborne's most recent trade in Adial Pharmaceuticals Inc was a trade of 138,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 138,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Claiborne J Cary | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 420,000 | 1,520,000 (14%) | 4% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.42 per share. | 19 Sep 2022 | 75,000 | 1,100,000 (10%) | 0% | 0.4 | 31,515 | Common Stock |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.43 per share. | 19 Sep 2022 | 25,000 | 1,025,000 (9%) | 0% | 0.4 | 10,735 | Common Stock |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 1,000,000 | 1,000,000 (9%) | 9% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 6,667 | 6,667 | - | - | Employee Stock Option | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 130,000 | 130,000 | - | - | Stock options | |
| Adial Pharmaceuticals Inc | Cary J Claiborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 60,000 | 60,000 | - | - | Stock Option |